0 results available. Select is focused ,type to refine list, press Down to open the menu,
Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. The company operates t...
We've identified the following companies as similar to Aclaris Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Gross Profit Margin in the efficiency category include:
Gross profit expressed as a percent of revenue.
The gross profit margin measures a company’s gross profit as a percentage of the revenue. The formula to calculate gross profit margin and an example calculation for Aclaris Therapeutics’s trailing twelve months is outlined below:
Gross Profit Margin = Gross Profit / Total Revenue
−162.0% = -30.324 M / 18.72 M
The tables below summarizes Aclaris Therapeutics’s performance over the last five years:
| Fiscal Year | Gross Profit | Revenue | Margin |
|---|---|---|---|
| 2020-12-31 | -27.989 M | 6.482 M | −431.8% |
| 2021-12-31 | -41.765 M | 6.761 M | −617.7% |
| 2022-12-31 | -60.021 M | 29.752 M | −201.7% |
| 2023-12-31 | -82.997 M | 31.249 M | −265.6% |
| 2024-12-31 | -30.324 M | 18.72 M | −162.0% |
The tables below summarizes Aclaris Therapeutics’s performance over the last four quarters:
| Quarter Ending | Gross Profit | Revenue | Margin |
|---|---|---|---|
| 2024-03-31 | -9.287 M | 2.398 M | −387.3% |
| 2024-06-30 | -7.902 M | 2.766 M | −285.7% |
| 2024-09-30 | 814 T | 4.346 M | 18.7% |
| 2024-12-31 | -31.484 M | 9.211 M | −341.8% |
You can read more about Gross Profit here.
The chart above depicts the distribution of gross profit margin for companies operating in the Healthcare sector in the Developed economic region. Over 2,020 companies were considered in this analysis, and 1,961 had meaningful values. The average gross profit margin of companies in the sector is -24.4% with a standard deviation of 375.9%.
Aclaris Therapeutics Inc's Gross Profit Margin of -162.0% ranks in the 8.3% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,022 |
| Included Constituents | 1,961 |
| Min | -4,603.7% |
| Max | 100.0% |
| Median | 50.0% |
| Mean | -24.4% |
| Standard Deviation | 375.9% |
You can find companies with similar gross profit margin using this stock screener.